0001061983-21-000102.txt : 20210405 0001061983-21-000102.hdr.sgml : 20210405 20210405185029 ACCESSION NUMBER: 0001061983-21-000102 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210401 FILED AS OF DATE: 20210405 DATE AS OF CHANGE: 20210405 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: HENDERSON JOHN T CENTRAL INDEX KEY: 0001226488 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-50633 FILM NUMBER: 21807353 MAIL ADDRESS: STREET 1: 320 WAKARA WAY CITY: SALT LAKE CITY STATE: UT ZIP: 84108 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CYTOKINETICS INC CENTRAL INDEX KEY: 0001061983 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 943291317 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 280 EAST GRAND AVENUE STREET 2: . CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: (650) 624-3000 MAIL ADDRESS: STREET 1: 280 EAST GRAND AVENUE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 4 1 edgardoc.xml PRIMARY DOCUMENT X0306 4 2021-04-01 0 0001061983 CYTOKINETICS INC CYTK 0001226488 HENDERSON JOHN T 280 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080 1 0 0 0 Common Stock 2021-04-01 4 M 0 1133 8.64 A 8543 D Common Stock 2021-04-01 4 S 0 1133 24.0 D 7410 D Common Stock 2021-04-01 4 M 0 1100 8.64 A 8510 D Common Stock 2021-04-01 4 S 0 1100 23.31 D 7410 D Common Stock 2021-04-01 4 M 0 1100 8.64 A 8510 D Common Stock 2021-04-01 4 S 0 1100 23.31 D 7410 D Common Stock 83 I by Spouse Non-Qualified Stock Option (right to buy) 8.64 2021-04-01 4 M 0 1133 0.0 D 2011-06-18 2021-05-18 Common Stock 1133 2200 D Non-Qualified Stock Option (right to buy) 8.64 2021-04-01 4 M 0 1100 0.0 D 2011-06-18 2021-05-18 Common Stock 1100 1100 D Non-Qualified Stock Option (right to buy) 8.64 2021-04-01 4 M 0 1100 0.0 D 2011-06-18 2021-05-18 Common Stock 1100 0 D Transaction effected pursuant to a 10b5-1 plan entered into by the Reporting Person on March 2, 2021 Amount includes 511 shares of common stock received at Reporting Person's election pursuant Issuer's stock in lieu of cash for all or part of directors' annual base retainer program. By: Robert Wong For: John T. Henderson 2021-04-05